Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
33%
Ph phase_3
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 32 (66.7%)
Phase 41 (33.3%)

Trials by Status

not_yet_recruiting267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_3

Stratification and Treatment in Early Psychosis Study -ASSIST

NCT07326124
not_yet_recruitingphase_3

Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

NCT07282249
unknownphase_4

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

NCT04735965

Clinical Trials (3)

Showing 3 of 3 trials
NCT07326124Phase 3

Stratification and Treatment in Early Psychosis Study -ASSIST

Not Yet Recruiting
NCT07282249Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B

Not Yet Recruiting
NCT04735965Phase 4

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3